Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

David P Kodack

3PUBLICATIONS

30CO-AUTHORS

Powder and particle technologyBiologically active moleculesMolecular targets

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (3)

Sort by Publication Date:

|Jun 17, 2024

Author Correction: Direct and selective pharmacological disruption of the YAP-TEAD interface by IAG933 inhibits Hippo-dependent and RAS-MAPK-altered cancers.

Emilie A Chapeau, Laurent Sansregret, Giorgio G Galli

|Apr 02, 2024

Direct and selective pharmacological disruption of the YAP-TEAD interface by IAG933 inhibits Hippo-dependent and RAS-MAPK-altered cancers.

Emilie A Chapeau, Laurent Sansregret, Giorgio G Galli

|May 26, 2017

The brain microenvironment mediates resistance in luminal breast cancer to PI3K inhibition through HER3 activation.

David P Kodack, Vasileios Askoxylakis, Gino B Ferraro

Pageof 1

Frequent Collaborators

2 joint publications

Thanos P Mourikis

2 joint publications

Nicolas Soldermann

2 joint publications

Clemens Scheufler

2 joint publications

Sabrina Baltschukat

2 joint publications

Tobias Schmelzle

2 joint publications

Luca Tordella

2 joint publications

Markus Wartmann

2 joint publications

Holger Sellner

2 joint publications

Daniel Bauer

2 joint publications

Giorgio G Galli

Frequent Collaborators

2 joint publications

Thanos P Mourikis

2 joint publications

Nicolas Soldermann

2 joint publications

Clemens Scheufler

2 joint publications

Sabrina Baltschukat

Top Related Videos

Monitoring Hippo Signaling Pathway Activity Using a Luciferase-based Large Tumor Suppressor (LATS) Biosensor

Monitoring Hippo Signaling Pathway Activity Using a Luciferase-based Large Tumor Suppressor (LATS) Biosensor

Published on : Sep 13, 2018

Phospholipid Mediator Induced Transformation in Three-Dimensional Cultures

Phospholipid Mediator Induced Transformation in Three-Dimensional Cultures

Published on : Jul 27, 2022

See more related videos

Top Related Videos

Monitoring Hippo Signaling Pathway Activity Using a Luciferase-based Large Tumor Suppressor (LATS) Biosensor

Monitoring Hippo Signaling Pathway Activity Using a Luciferase-based Large Tumor Suppressor (LATS) Biosensor

Published on : Sep 13, 2018

Phospholipid Mediator Induced Transformation in Three-Dimensional Cultures

Phospholipid Mediator Induced Transformation in Three-Dimensional Cultures

Published on : Jul 27, 2022

See more related videos